Cargando…
Treatment Stratification of Patients with Metastatic Castration-Resistant Prostate Cancer by Machine Learning
Prostate cancer is the most common cancer in men in the Western world. One-third of the patients with prostate cancer will develop resistance to hormonal therapy and progress into metastatic castration-resistant prostate cancer (mCRPC). Currently, docetaxel is a preferred treatment for mCRPC. Howeve...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6976944/ https://www.ncbi.nlm.nih.gov/pubmed/31978751 http://dx.doi.org/10.1016/j.isci.2019.100804 |